Contribution: Industrial Research Assistance Program – Contributions to Firms
Equicare Health Inc
$145,000.00
ProXimity Project No. 2: Clinical-trial Sponsor Platform
EF 2021-22 · 2021-09-01
Résumé
This project concerns the development, in-house testing and in-field validation of several enhancements to the firm's clinical-trial sponsor platform. The envisioned enhancements will be implemented to address concerns relating to the firm's experience in enrolling new clinical-trial sites and end-users, feedback the firm has received thus far from a variety of stakeholders and recently-identified market opportunities.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Vancouver|Vancouver, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
894981414
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 91 days. The total amended value is 145,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 91 jours. La valeur totale des modifications est de 145 000 dollars.
Agreement End Date
2022-06-30
Agreement Number
979314
Agreement Start Date
2021-09-01
Agreement Title
ProXimity Project No. 2: Clinical-trial Sponsor Platform
Agreement Title (French)
Projet ProXimity n° 2 : Plate-forme de promotion d'essais cliniques
Agreement Type
Contribution
Agreement Value
$145,000.00
Amendment Date
2021-11-23
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project concerns the development, in-house testing and in-field validation of several enhancements to the firm's clinical-trial sponsor platform. The envisioned enhancements will be implemented to address concerns relating to the firm's experience in enrolling new clinical-trial sites and end-users, feedback the firm has received thus far from a variety of stakeholders and recently-identified market opportunities.
Description (French)
Ce projet concerne le développement, les tests internes et la validation sur le terrain de plusieurs améliorations de la plateforme de parrainage d'essais cliniques de l'entreprise. Les améliorations envisagées seront mises en œuvre pour répondre aux préoccupations liées à l'expérience de l'entreprise dans l'inscription de nouveaux sites d'essais cliniques et d'utilisateurs finaux, aux commentaires que l'entreprise a reçus jusqu'à présent d'une variété de parties prenantes et aux possibilités de marché récemment déterminées.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Granville
Federal Riding (French)
Vancouver Granville
Federal Riding Number
59036
NAICS Code
541514
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
894981414
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Equicare Health Inc
Recipient Postal Code
V5Y 3W2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2021-2022-Q3-979314
